Intriguingly, the inhibition of AKT does not entirely eliminate the tumor-promoting effects and the upregulated β-catenin-mediated signaling resulting from ACTN1 overexpression, suggesting the possibility of additional underlying molecular mechanisms. The gene discussed is ACTN1; the disease is neoplasm.